Otonomy Competitors and Similar CompaniesClear all
Otonomy's competitors and similar companies include BeyondSpring.
 Otonomy Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear. |  BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. | |
Founding Date | Founding Date 2008 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Florham Park, US HQ |
Employees | Employees 49 | Employees 4014% increase |
Valuation ($) | Valuation ($) 5.3 m | Valuation ($) 89.4 m |
Financial | ||
Net income | Net income ($51.2m) (FY, 2021) | Net income ($16.7m) (FY, 2024) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 2 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products 2 (FY, 2016) | Phase II Trials Products 1 (FY, 2017) |
Phase III Trials Products | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products 3 (FY, 2019) |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 1 (FY, 2016) | Pre-Clinical Phase Products 5 (FY, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 153.4m | Total funding raised $ 36.1m |
For sources of this data, please see the company profile
View Company Profiles
BeyondSpring
HQ
Florham Park, US
Employees
40↑ 14% increase
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View company